Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Anja Tröger"'
Autor:
Gabriele Escherich, Anja Tröger, Ulrich Göbel, Ulrike Graubner, Arnulf Pekrun, Norbert Jorch, Gjl Kaspers, Martin Zimmermann, Udo zur Stadt, Karin Kazemier, Rob Pieters, Monique L. Den Boer, Martin Horstmann, Gritta E. Janka
Publikováno v:
Haematologica, Vol 96, Iss 6 (2011)
Background In a study of childhood acute lymphoblastic leukemia (CoALL 06-97 study), the in vitro sensitivity of the patients’ cells to prednisolone, vincristine and asparaginase was introduced as a new additional risk parameter for treatment strat
Externí odkaz:
https://doaj.org/article/90bdd4516ab64d82b37e9388534e95f0
Autor:
Muriel Malaisé, Tilman Heise, Jürgen Föll, Anja Tröger, Gunhild Sommer, Marie Matthes, Daniel Wolff, Raphaela Mueckenhausen, Selim Corbacioglu, Ernst Holler, Katharina Kleinschmidt
Publikováno v:
Hematology/Oncology and Stem Cell Therapy.
Some of the early complications of hematopoietic stem cell transplantation (HSCT) concerning the small vessels can be summarized as transplant-associated systemic vasculopathies (TASV). One enzyme known to play a major role in inflammation, tissue re
Autor:
Gertjan J.L. Kaspers, Ulrich Göbel, Arnulf Pekrun, Rob Pieters, Karin M. Kazemier, Udo zur Stadt, Martin A. Horstmann, Norbert Jorch, Anja Tröger, Martin Zimmermann, Gabriele Escherich, Ulrike Graubner, Monique L. den Boer, Gritta Janka
Publikováno v:
Escherich, G, Troger, A, Gobel, U, Graubner, U, Pekrun, A, Jorch, N, Kaspers, G J L, Zimmermann, M, Stadt, U Z, Kazemier, K, Pieters, R, den Boer, M L, Horstmann, M & Janka, G E 2011, ' The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97) ', Haematologica, vol. 96, no. 6, pp. 854-862 . https://doi.org/10.3324/haematol.2010.039735
Haematologica, 96(6), 854-862. Ferrata Storti Foundation
Haematologica, 96(6), 854-862. Ferrata Storti Foundation
In a study of childhood acute lymphoblastic leukemia (CoALL 06-97 study), the in vitro sensitivity of the patients' cells to prednisolone, vincristine and asparaginase was introduced as a new additional risk parameter for treatment stratification. In
Autor:
Dagmar Dilloo, Monika Schmitz, Anja Tröger, Christof M. Kramm, Kumar Sinha, Johannes C. Fischer, Hans-Jürgen Laws, Stefan Schönberger, Jürgen Enczmann, Ulrich Göbel, Roland Meisel, B Bernbeck, Stefan Balzer
Publikováno v:
Biology of Blood and Marrow Transplantation. 13(11):1338-1345
Despite the increasing use of peripheral blood progenitor cells (PBPC) instead of bone marrow (BM) for allogeneic hematopoietic stem cell transplantation (allo HSCT) from human leukocyte antigen (HLA)-matched unrelated donors in children, the relativ
Autor:
Stefan Balzer, B Bernbeck, Ulrich Göbel, K. Sinha, Roland Meisel, Stefan Schönberger, Christof M. Kramm, Anja Tröger, P. Wernet, Hans-Jürgen Laws, Jürgen Enczmann, Dagmar Dilloo
Publikováno v:
Klinische Pädiatrie. 217:135-141
Background: Peripheralblood stem cell (PBSC)g rafts arei ncreasinglyu sed forautologous and allogeneichaemat opoietic stem cell transplantation (alloHSCT)withth e aim toh asten neutrophil and plateletengraftm entand therebyt oreducetransplant-related
Publikováno v:
The Cancer Handbook
Immunotherapy of cancer has emerged as a promising new strategy to complement standard anticancer therapies such as chemotherapy, surgery, and radiotherapy. While the currently available data from clinical trials of cancer vaccines provide evidence f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae3eb2140534d087d901fe754fd25c91
https://doi.org/10.1002/9780470025079.chap68.pub2
https://doi.org/10.1002/9780470025079.chap68.pub2
Autor:
Hans-Jürgen Laws, Anja Tröger, H. Bülle, Dagmar Dilloo, N. Wethkamp, Meinolf Siepermann, Gabriele Escherich, C. Mahotka, G. E. Janka-Schaub, Ulrich Göbel
Publikováno v:
Klinische Padiatrie. 219(3)
BACKGROUND Survivin, a member of the inhibitor of apoptosis protein (IAP) family is transiently expressed at low levels during normal hematopoesis but profoundly overexpressed in adult leukemia potentially contributing to leukemogenesis due to deregu
Autor:
K. Recker, Uta Dirksen, Hans-Jürgen Laws, Sonja Gudowius, Helmut Hanenberg, S. Furlan, Anja Tröger, U. Wieczorek, Ulrich Göbel
Publikováno v:
Klinische Padiatrie. 218(6)
BACKGROUND Contemporary risk adapted treatment protocols for childhood acute lymphoblastic leukemia (ALL) rely on accurate risk assessment strategies for disease re-occurrence by incorporating clinical parameters as well as immunological, molecular a